A study of Killip class in patients with acute myocardial infarction on day 0, day 3, day 7

 

Triveni Ayyanna¹, Ashok Thaned^2*

 

REFERENCES

1. Yusuf S1, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): Case-control study. Lancet. 2004;364(9438):937-52.
2. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic,functional, and hemodynamic staging. Circulation. 2003;107:1991-97.
3. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J. 1997;18:858-65.
4. A llison TG. Coronary heart disease epidemiology. In: Murphy JG, Lloyd MA, editors. Mayo clinic cardiology. 3rd edition. Rochester (MN): Mayo Clinic Scientific Press. 2007;687-93.
5. Ochiai ME, Barretto AC, Oliveira MT Jr, Munhoz RT, Morgado PC, Ramires JA. Uric acid renal excretion and renal in sufficiency in decompensated severe heart failure. Eur J Heart Fail. 2005;7:468-74.
6. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;21:1685-95.
7. Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S, Yamagishi M, et al. Prognostic usefulness of serum uric acid after acute myocardial infarction(Japanese Acute Coronary Syndrome Study).Am J Cardiol. 2005;96:489-95.
8. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-64.
9. Mello, B. H. G. D., Oliveira, G. B. F., Ramos, R. F., Lopes, B. B. C., Barros, C. B. S., Carvalho, E. D. O., ... and Piegas, L. S. (2014). Validation of the Killip-Kimball Classification and Late Mortality after Acute Myocardial Infarction.Arquivos brasileiros de cardiologia, 103(2), 107-117.
10. Khot, U. N., Jia, G., Moliterno, D. J., Lincoff, A. M., Khot, M. B., Harrington, R. A., and Topol, E. J. (2003). Prognostic importance of physical examination for heart failure in non–ST-elevation acute coronary syndromes: the enduring value of Killip classification. Jama, 290(16), 2174-2181.
11. Granger, C. B., Goldberg, R. J., Dabbous, O., Pieper, K. S., Eagle, K. A., Cannon, C. P., ... and Fox, K. A. (2003). Predictors of hospital mortality in the global registry of acute coronary events. Archives of internal medicine, 163(19), 2345-2353.
12. Lee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., ... and Califf, R. M. (1995). Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction Results from an International Trial of 41 021 Patients. Circulation, 91(6), 1659-1668.
13. Nozari, Y., and Geraiely, B. (2011). Correlation between the serum levels of uric acid and HS-CRP with the occurrence of early systolic failure of left ventricle following acute myocardial infarction. Acta Medica Iranica, 49(8), 531-535.
14. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, and Breteler MM (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke37: 1503–150.
15. Alderman, M. H. (2007). Podagra, uric acid, and cardiovascular disease.Circulation, 116(8), 880-883.
16. Gertler MM, Gam SM, Levine SA. Serum uric acid in relation to age and physique in health and coronary heart disease. Ann Intern Med. 1951;34: 1421–1431.
17. Gupta R. Burden of coronary heart disease in India. Indian Heart J 2005; 57: 6328.
18. L S Patil, Amith Gupta, Timmanna Giradd. Study of serum uric acid levels in acute ST elevation myocardial infarction patients and its correlation with Killip’s classification of heart failure. International Journal of Biomedical and Advance Research 2015; 6(09): 673-677.